To determine the pathways associated with IGF2BP3 expression in bladder cancer, we utilized Gene Set Enrichment Analysis (GSEA) to identify gene sets that exhibited enrichment or depletion in tumors with high IGF2BP3 expression. The gene discussed is IGF2BP3; the disease is urinary bladder cancer.